NCT05137418View on ClinicalTrials.gov

Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

PHASE3CompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 27, 2021

Primary Completion Date

January 27, 2023

Study Completion Date

January 27, 2023

Conditions

COVID-19

Interventions

BIOLOGICAL

COVID-19 Vaccine,Inactivated

The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd..600SU Inactivated SARS-COV-2 virus in 0·5 mL of aluminium hydroxide solution per injection

Trial Locations (1)

224300

Sheyang County Center for Disease Control and Prevention, Yancheng

All Listed Sponsors

lead

Sinovac Research and Development Co., Ltd.

INDUSTRY

NCT05137418 - Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years | Biotech Hunter | Biotech Hunter